Schoenberg Mark bought URGN
July 28, 2025 · Form 4 insider transaction
Schoenberg Mark bought 10,000 shares of UroGen Pharma Ltd., a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
10,000
Price
N/A
Total value
N/A
InsiderSchoenberg Mark
Role—
CompanyUroGen Pharma Ltd. (URGN)
SecurityOrdinary Shares
Transaction codeM: Option exercise
Transaction dateJuly 28, 2025
Filing dateJuly 30, 2025
Shares owned after163,378
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents the settlement of performance stock units granted on January 31, 2024 that vested upon the achievement of a corporate milestone event.; Each performance stock unit represents a contingent right to receive one ordinary share of the Issuer.